3,401 results on '"Mikhailidis, Dimitri P."'
Search Results
52. Carotid Plaque-RADS, a novel stroke risk classification system
53. Link between plasma trans-fatty acid and fatty liver is moderated by adiposity
54. Dietary inflammatory index and cardiometabolic risk in US adults
55. The Role of Nutraceuticals in Statin Intolerant Patients
56. Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
57. Statin Intolerance: Some Practical Hints
58. Lipid-lowering treatment in peripheral artery disease
59. The link between insulin resistance parameters and serum uric acid is mediated by adiposity
60. Comment on “Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men: The Challenges Remain”
61. Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management
62. Optimal Stroke Risk Management in Carotid Atherosclerotic Disease: A Patient-Centered Multidisciplinary Approach
63. The Effect of Menopause and Menopausal Hormone Therapy on the Risk of Peripheral Artery Disease
64. Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis
65. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
66. Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
67. Statins and Niacin: The End of Residual Risk Therapy?
68. Drug Evaluation: The Combination of Fenofibrate and Simvastatin for the Treatment of Dyslipidemia: When and for Whom?
69. Statins and Fibrates: Should They Be Recommended?
70. Lipids: a personal view of the past decade
71. Leptin, cardiovascular diseases and type 2 diabetes mellitus
72. Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
73. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
74. Epicardial, peripancreatic and other “orthotopic” excessive fat deposition in south Asians and Europeans: Are differences clinically relevant?
75. Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview
76. Lipid-modifying effects of nutraceuticals: An evidence-based approach
77. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms
78. Assessment of postprandial triglycerides in clinical practice: Validation in a general population and coronary heart disease patients
79. Non-alcoholic fatty liver disease and dyslipidemia: An update
80. Does bilirubin protect against developing diabetes mellitus?
81. Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies
82. NAFLD and Statins
83. Prehypertension, the Risk of Hypertension and Events
84. Mean platelet volume and coronary artery disease
85. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
86. Asymptomatic carotid stenosis and cognitive impairment
87. Screening for asymptomatic carotid stenosis in patients with non-valvular atrial fibrillation
88. Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?
89. Clarifying the rationale supporting selective screening for asymptomatic carotid artery stenosis
90. COWBOYS and INDIAN: A Doctor’s First Year in Texas
91. Abdominal aortic aneurysms and diabetes mellitus
92. Endocan: A novel inflammatory indicator in cardiovascular disease?
93. Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients
94. A possible relationship between renal impairment and complications development in type 2 diabetes mellitus: a prospective, observational study in Italy
95. Effects of oral hypoglycemic agents on platelet function
96. Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials
97. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society
98. Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials
99. Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients
100. High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.